Immunostimulatory activity of CpG oligonucleotides containing non-ionic methylphosphonate linkages

被引:45
作者
Yu, D [1 ]
Kandimalla, ER [1 ]
Zhao, QY [1 ]
Cong, YP [1 ]
Agrawal, S [1 ]
机构
[1] Hybridon Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1016/S0968-0896(01)00142-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bacterial DNA and synthetic oligodeoxynuelcotides containing unmethylated CpG-motifs in a particular sequence context activate vertebrate immune cells. We examined the significance of negatively charged internucleoside linkages in the flanking sequences 5' and 3' to the CpG-motif on immunostimulatory activity. Cell proliferation and secretion of IL-12 and IL-6 in mouse spleen cell cultures, and spleen weights of mice increased significantly when a non-ionic linkage was placed at least four or more internucleoside linkages away from the CpG-motif in the 5'-flanking sequence. When the non-ionic linkage was placed closer than three internucleoside linkages in the 5'-flanking sequence to the CpG-motif, immunostimulatory activity was suppressed compared with that observed with the unmodified parent oligo. In general, the placement of non-ionic linkage in the 3'-flanking sequence to the CpG-motif either did not affect or slightly increased immunostimulatory activity compared with the parent oligo. These results have significance in understanding CpG oligonucleotide-receptor interactions and the development of potent immunomodulatory agents. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2803 / 2808
页数:6
相关论文
共 23 条
[1]   How do you see CG? [J].
Aderem, A ;
Hume, DA .
CELL, 2000, 103 (07) :993-996
[2]   Antisense therapeutics: is it as simple as complementary base recognition? [J].
Agrawal, S ;
Kandimalla, ER .
MOLECULAR MEDICINE TODAY, 2000, 6 (02) :72-81
[3]   OLIGODEOXYNUCLEOSIDE METHYLPHOSPHONATES - SYNTHESIS AND ENZYMATIC DEGRADATION [J].
AGRAWAL, S ;
GOODCHILD, J .
TETRAHEDRON LETTERS, 1987, 28 (31) :3539-3542
[4]   IMMUNE STIMULATION BY AN ANTISENSE OLIGOMER COMPLEMENTARY TO THE REV GENE OF HIV-1 [J].
BRANDA, RF ;
MOORE, AL ;
MATHEWS, L ;
MCCORMACK, JJ ;
ZON, G .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) :2037-2043
[5]  
Carpentier AF, 2000, CLIN CANCER RES, V6, P2469
[6]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631
[7]   RETRACTED: DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA (Retracted Article) [J].
Chu, WM ;
Gong, X ;
Li, ZW ;
Takabayashi, K ;
Ouyang, HH ;
Chen, Y ;
Lois, A ;
Chen, DJ ;
Li, GC ;
Karin, M ;
Raz, E .
CELL, 2000, 103 (06) :909-918
[8]   Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity [J].
Davila, E ;
Celis, E .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :539-547
[9]   CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans [J].
Davis, HL ;
Suparto, I ;
Weeratna, R ;
Jumintarto ;
Iskandriati, D ;
Chamzah, S ;
Ma'ruf, A ;
Nente, C ;
Pawitri, D ;
Krieg, AM ;
Heriyanto ;
Smits, W ;
Sajuthi, D .
VACCINE, 2000, 18 (18) :1920-1924
[10]  
DUNFORD PJ, 1997, ANTISENSE 97 TARGETI, P40